Items tagged with Drug-resistant TB
MSF responds to TB Alliance announcement of the Nix-TB clinical trial (post)
On 13 May, TB Alliance announced the start of its Nix-TB (New Investigational Drugs for XDR-TB) clinical trial, the first to test a new all-oral regimen for extensively drug-resistant tuberculosis (XDR-TB).
SA hosts world’s first study into better XDR-TB treatment (post)
South African scientists are spearheading the world’s first trial into shorter and better treatment for tuberculosis (XDR-TB), which kills about half of all those diagnosed with the condition in South Africa.
New test could identify resistant tuberculosis faster (post)
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
Lakewood-Amedex announces its novel bisphospocin® class of antimicrobials kills multidrug-resistant tuberculosis (MDR-TB) strains in fifteen minutes (post)
SARASOTA, Fla., May 19, 2015 -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis. Approximately one-third of the world's population is infected by this bacteria, which is increasingly becoming resistant to the current five-drug cocktail used to treat these infections. This issue is sparking serious concern in world health organizations and medical communities as they no longer have an effective cure for many of these patients.
Workshop on use of bedaquiline to treat extensively drug-resistant tuberculosis (XDR-TB) in Belarus (post)
The National Tuberculosis Programme (NTP) in Belarus, in collaboration with WHO and with the support of the United Nations Development Programme; the Global Fund to Fight AIDS, TB and Malaria (the Global Fund); and Médecins Sans Frontières, organized a workshop on "The use of bedaquiline to treat XDR-TB" on 7 May 2015 at the Republican Scientific and Practical Centre for Pulmonology and Tuberculosis in Minsk, Belarus. The training was conducted by WHO and national experts from NTP and the National Pharmacovigilance Centre and was attended by 28 participants.
'Imperfect drug penetration' speeds pathogens' resistance, study finds (post)
SAN FRANCISCO, May 18, 2015 -- Prescribing patients two or more drugs that do not reach the same parts of the body could accelerate a pathogen's resistance to all of the drugs being used in treatment, according to a new study published today in the Proceedings of the National Academy of Sciences.
Eastern Cape treatment dysfunction boosts virulent new XDR-TB strain (post)
At least half of all known drug-resistant tuberculosis (DR-TB) patients in the Port Elizabeth area (and possibly the entire Eastern Cape) are being treated with too few drugs, fuelling the spread of extensively drug-resistant (XDR)-TB and condemning them to death.
WHA committees approve plans on antimicrobial resistance, vaccines, innovation (post)
Today (May 25), member states in committee at the World Health Assembly adopted the first global plan of action to address the issue of antimicrobial resistance, and a global plan of action on vaccines. In addition, a mechanism on public health, innovation and intellectual property was postponed until 2022, and a deadline for its evaluation moved to 2018.
New online tool to predict genetic resistance to tuberculosis drugs (post)
Finding out what drugs can be used to treat a patient with tuberculosis (TB) can be sped up by days or weeks, thanks to a new free online tool.
One in eight TB cases in children is isoniazid-resistant (post)
Isoniazid-resistant tuberculosis (TB) is more common than had been thought among children, particularly in Europe, according to the results of a study published online June 1 in Pediatrics.
Page 15 of 117 · Total posts: 0
←First 14 15 16 Last→